NVG, LLC for PFIZER INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property, data exclusivity and patent eligibility, generally; CREATES Act of 2019 (S.340)/(H.R.965); Preserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); Affordable Prescriptions for Patients Act (S.1416); Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3991); Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398); Protecting Consumer Access to Generic Drugs Act (H.R. 1499).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Budget/Appropriations BUD
Childhood vaccination coverage disparities under Medicaid and CHIP, biosimilars, and non-opioid treatments in the House and Senate FY 2020 LHHS Appropriations bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
| ANDREA LARUE | — |
| JANE LOEWENSON | — |
Health Issues HCR
Prescription drug coverage and payment policies; Medical innovation issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| ANDREA LARUE | — |
| EDEN SHIFERAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.